Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Sarcopenia 1Postoperative Complications 1Peritoneal Neoplasms 1Neoplasms 1Intestinal Perforation 1Diverticulosis, Colonic 1Diverticulitis 1Colonic Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 5Mitomycin 3Irinotecan 3Hyperthermic Intraperitoneal Chemotherapy 3Capecitabine 3Trastuzumab 2Thalidomide 2Leucovorin 2Interleukin-12 Subunit p35 2Cisplatin 2tipifarnib 1nilotinib 1entinostat 1durvalumab 1Yoga 1Watchful Waiting 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Referral and Consultation 1Quality of Life 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Patient Reported Outcome Measures 1Paclitaxel 1Ondansetron 1Molecular Diagnostic Techniques 1Melphalan 1Laparoscopy 1Interleukin-12 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Appendiceal Neoplasms × Colectomy × Clear all
NCT05452382 2022-07-11

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

Mansoura University

Completed
2,607 enrolled
Gastrointestinal

Appendiceal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡